⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

August 1, 2024Open Access

Figure S10 from Venetoclax Induces BCL-2–Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade

Rosy Liao Jocelyn Y. Hsu Nada S. Aboelella Joshua A. McKeever Anika Thomas-Toth Andrew S. Koh James L. LaBelle

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Supplementary Figure S10. Percentage of RORγt+ Tregs in the (A) spleens (B) draining lymph nodes, and (C) tumors of Foxp3eGFP-Cre-ERT2 Bcl2fl/fl 7 days into treatment as shown in Fig. 7. Data represented as means ± SD. *p < 0.05, **p <0.01, ***p < 0.001.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liao et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e0b6db64358757502e https://doi.org/10.1158/2326-6066.26422661.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S7 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
2Figure S4 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
3Figure S2 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
4Figure S8 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
5Figure S5 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
6Figure S3 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
7Figure S6 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024
8Figure S9 from Venetoclax Induces BCL-2–Dependent Treg to T<sub>H</sub>17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade2024